- increased bone mineral density / IMPC
- abnormal vertebrae morphology / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased body weight / IMPC
- abnormal cornea morphology / IMPC
- abnormal eye morphology / IMPC
- abnormal tail morphology / IMPC
- abnormal eye size / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating serum albumin level / IMPC
- corneal vascularization / IMPC
- decreased circulating total protein level / IMPC
- decreased total body fat amount / IMPC
- process of degenerative change / IMPC
- inflammation / IMPC
- developmental dysplasia / IMPC
C57BL/6NTac-Pex3tm1a(EUCOMM)Wtsi/WtsiOrl
Status | Available to order |
EMMA ID | EM:05793 |
International strain name | C57BL/6NTac-Pex3tm1a(EUCOMM)Wtsi/WtsiOrl |
Alternative name | EPD0103_1_H06 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Pex3tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Pex3 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0103_1_H06. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6N Tac |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Zellweger syndrome / Orphanet_912
- Neonatal adrenoleukodystrophy / Orphanet_44
- Infantile Refsum disease / Orphanet_772
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased body weight / IMPC
- abnormal eye morphology / IMPC
- abnormal vertebrae morphology / IMPC
- corneal vascularization / IMPC
- increased bone mineral density / IMPC
- inflammation / IMPC
- decreased circulating HDL cholesterol level / IMPC
- abnormal tail morphology / IMPC
- decreased circulating serum albumin level / IMPC
- abnormal eye size / IMPC
- abnormal cornea morphology / IMPC
- decreased circulating total protein level / IMPC
- process of degenerative change / IMPC
- developmental dysplasia / IMPC
- decreased total body fat amount / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating LDL cholesterol level / IMPC
MGI phenotypes (allele matching)
- increased bone mineral density / MGI
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal sebaceous gland morphology / MGI
- decreased body weight / MGI
- abnormal cornea morphology / MGI
- decreased caudal vertebrae number / MGI
- abnormal eye morphology / MGI
- abnormal tail morphology / MGI
- abnormal eye size / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating cholesterol level / MGI
- decreased circulating serum albumin level / MGI
- increased mean corpuscular hemoglobin / MGI
- decreased circulating total protein level / MGI
- decreased circulating aspartate transaminase level / MGI
- abnormal hair follicle bulge morphology / MGI
- decreased total body fat amount / MGI
- increased circulating fructosamine level / MGI
- decreased circulating fructosamine level / MGI
- increased sacral vertebrae number / MGI
- small sebaceous gland / MGI
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal sebaceous gland morphology / MGI
- decreased body weight / MGI
- abnormal cornea morphology / MGI
- decreased caudal vertebrae number / MGI
- abnormal eye morphology / MGI
- abnormal tail morphology / MGI
- abnormal eye size / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating cholesterol level / MGI
- decreased circulating serum albumin level / MGI
- increased mean corpuscular hemoglobin / MGI
- decreased circulating total protein level / MGI
- decreased circulating aspartate transaminase level / MGI
- abnormal hair follicle bulge morphology / MGI
- decreased total body fat amount / MGI
- increased circulating fructosamine level / MGI
- decreased circulating fructosamine level / MGI
- increased sacral vertebrae number / MGI
- small sebaceous gland / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).